Skip to main content
Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
13.00
+0.34 (2.69%)
At close: Aug 13, 2025, 4:00 PM
13.18
+0.18 (1.38%)
After-hours: Aug 13, 2025, 7:00 PM EDT

Adaptive Biotechnologies Revenue by Segment
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
MRD
171.28M 156.62M 145.53M 136.14M 123.34M 113.94M 102.74M 100.08M
MRD Growth
38.87% 37.46% 41.65% 36.03% 29.33% 25.53% 17.90% 32.40%
Immune Medicine
33.94M 32.90M 33.43M 41.14M 45.43M 60.56M 67.54M 79.61M
Immune Medicine Growth
-25.29% -45.67% -50.50% -48.32% -51.79% -35.27% -31.20% -13.89%

Immune Medicine Revenue Breakdown
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Immune Medicine Service
19.39M 20.54M 19.98M 23.27M 23.06M 22.42M 24.96M 28.66M
Immune Medicine Service Growth
-15.89% -8.37% -19.96% -18.79% -23.09% -29.43% -21.46% 2.98%
Collaboration
14.55M 12.36M 13.45M 17.87M 22.37M 38.15M 42.58M 50.95M
Collaboration Growth
-34.98% -67.59% -68.41% -64.93% -65.19% -38.27% -35.86% -21.15%

Adjusted EBITDA by Segment
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024
MRD
-14.87M -28.08M -41.22M
Immune
-23.56M -24.52M -26.01M

Number of Clonoseq Tests Delivered
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Number of Clonoseq Tests Delivered
88.98K 82.18K 76.11K 70.84K 66.31K 61.46K 56.50K 51.34K
Number of Clonoseq Tests Delivered Growth
34.19% 33.72% 34.71% 37.98% 44.41% 48.98% 53.23% 54.67%

MRD Revenue Breakdown
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Service
156.28M 144.12M 133.03M 123.64M 115.84M 109.44M 102.74M 98.08M
Service Growth
34.91% 31.69% 29.48% 26.06% 24.07% 24.69% 26.61% 37.00%
Regulatory Milestone
18.00M 17.00M - 14.50M 10.50M 10.50M - - - - 7.50M - 7.00M 13.00M -
Regulatory Milestone Growth
71.43% 126.67% - 107.14% -19.23% - - - - - - - - - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.